• Microchimerism: Lifelong Biological Connections Impacting Everyone

    Bio-IT World | During pregnancy, the cells of a fetus make their way into the tissues of mom where they can persist for decades, much like what happens when someone gets an organ transplant but to a far tinier extent. That the maternal-fetal exchange results in chimerism—more specifically, “microchimerism”—is a relatively little-known yet fascinating and profoundly common biological phenomenon.

    May 19, 2026

  • From Data Chaos to Discovery: Building the Data Foundation for AI-Ready Scientific Research

    Bio-IT World | Life sciences organizations have never generated more data — or struggled more to act on it. Genomics pipelines, imaging systems, and clinical analytics platforms each produce enormous volume, but rarely in ways that integrate cleanly across research workflows. The infrastructure that served the industry a decade ago wasn't built for this scale, or for the speed that modern discovery demands. AI doesn't fix that on its own.

    May 14, 2026

  • 36 New Products at Bio-IT World 2026

    Bio-IT World | Thirty-six new products are up for consideration at Bio-IT World next week where the community will choose 2026 Best of Show winners. The Best of Show Awards recognize the best new products in biotech and the life sciences. The competition is a new product competition open to any exhibiting company at Bio-IT World.

    May 13, 2026

  • 36 New Products at Bio-IT World 2026

    Bio-IT World | Thirty-six new products are up for consideration at Bio-IT World next week where the community will choose 2026 Best of Show winners. The Best of Show Awards recognize the best new products in biotech and the life sciences. The competition is a new product competition open to any exhibiting company at Bio-IT World.

    May 13, 2026

  • AI Framework for Differentiating Neurodegenerative Diseases

    Bio-IT World | A team of computational scientists at Lund University (Sweden) have built a deep, joint-learning proteomics model for improving the diagnostic accuracy for a handful of dementia-related conditions which in primary care settings remains challenging due to a shortage of informative biomarkers. Predicting these different but correlated pathologies together with a single blood test would facilitate a differential diagnosis with speed and confidence.

    May 12, 2026

  • Trends from the Trenches: The Capability Jump of AI and Its Impact

    Bio-IT World | A year ago, some would have said AI was not making an impact on drug development or computational biology. But Sonia Timberlake, R&D strategy consultant at Timberlake & Maclsaac Biopharma Consulting, argues that recent rapid innovation makes it hard to claim AI isn’t impacting computational biology anymore.

    May 7, 2026

  • Bacteria: Unsung Players in the Tumor Microbiome

    Bio-IT World | How cancer patients will respond to treatment can be anticipated based on their genetics as well as the tumor microenvironment, although one relevant component is often all but dismissed: the tumor microbiota. This is despite an abundance of evidence that a cancer’s microbial community plays a major role not only in therapeutic effects but also in tumor development, progression, and metastasis formation.

    May 6, 2026

  • Much Progress Needed Planning Research to Consider Sex as a Biological Variable

    Bio-IT World | In 2016, the National Institutes of Health (NIH) introduced a policy requiring grantees to consider sex as a biological variable in their experimental design, analyses, and reporting. Now a team from Northwestern University has assessed progress, highlighting significant room for improvement.

    May 5, 2026

  • Craig Venter, Genomics Pioneer and Visionary, Dies

    Bio-IT World | The J. Craig Venter Institute (JCVI) announced that J. Craig Venter, Ph.D., the Institute’s founder, board chair, and chief executive officer, died yesterday in San Diego following a brief hospitalization for unexpected side effects that arose from treatment of recently diagnosed cancer. He was 79

    Apr 30, 2026

  • Follow the Money: Autoimmune, Inflammatory Disease Therapies, Antibody-Drug Conjugates, AKT1-Selective Inhibitor Programs

    Bio-IT World | Beeline Medicines debuts and advances a differentiated pipeline of precision therapies; Syneron Bio advances proprietary macrocyclic peptide discovery platform, Synova; Terremoto Biosciences advances lead AKT1-selective inhibitor programs through phase 1 clinical development; and more.

    Apr 30, 2026

  • Bio-IT World Honors Four 2026 Innovative Practices Winning Projects

    Bio-IT World | Bio-IT World is pleased to announce the 2026 Innovative Practices Award Winners. Prize-winning collaborations came from teams at Arizona State University, Center for Evolution and Medicine, Starfish Storage, CareDx, ASAP Discovery Consortium, Novartis, and Genedata AG.

    Apr 29, 2026

  • Bio-IT World Honors Four 2026 Innovative Practices Winning Projects

    Bio-IT World | Bio-IT World is pleased to announce the 2026 Innovative Practices Award Winners. Prize-winning collaborations came from teams at Arizona State University, Center for Evolution and Medicine, Starfish Storage, CareDx, ASAP Discovery Consortium, Novartis, and Genedata AG.

    Apr 29, 2026

  • Cepheid, Oxford Nanopore Expand Partnership, Revvity Launches New Platform, More

    Bio-IT World | The first quantum genome; Cepheid and Oxford Nanopore expand their partnership; Revvity launch Signals BioDesign; PathAI and MedStar Health enter multi-year strategic collaboration; and more.

    Apr 28, 2026

  • fMRI-Based Mega-Study of Psychedelics Reveals Patterns of Brain Signaling Reorganization

    Bio-IT World | Psychedelics are receiving increased attention for their potential to treat various mental health conditions. Just this week, an executive order was signed directing the United States FDA, DEA, and HHS to facilitate, fund, and fast track clinical research and review of psychedelics.

    Apr 23, 2026

  • From Brain Implant to Lifelong Companion: Michel Maharbiz Unveils Epia Neuro

    Bio-IT World | Michel Maharbiz walked to the podium with an announcement and an apology. After years of incessant investor pitching in private, Maharbiz said, this was the first time he’d be speaking about the venture openly. What followed was part company reveal, part field critique, part vision statement and a pitch for nothing less than a new paradigm for how brain-computer interfaces are built, deployed, and kept alive in patients’ bodies over a lifetime.

    Apr 22, 2026

  • Investors Sound Off on BCI Hype, Regulatory Risk, and the AI Gold Rush

    Bio-IT World | JoJo Platt of Neurotech Reports opened her panel at the 2026 Bioelectronic Medicine Forum with her own notebook open. She has an upcoming appointment to talk to Congress about brain-computer interfaces, and she wanted her panel of investors to weigh in. They didn’t hesitate: the need for regulatory sandboxes, clearer reimbursement pathways, freedom from regulation burden, and more translational grant funding.

    Apr 21, 2026

  • SPT Labtech and EMBL GeneCore Team Up for Fully Walkaway Automated Genomics Workflows

    Bio-IT World | SPT Labtech and the European Molecular Biology Laboratory’s Genomics Core Facility (EMBL GeneCore) have entered a collaborative partnership to advance fully walkaway automated genomics workflows.

    Apr 16, 2026

  • AWS Launches Agentic Drug Discovery-Wet Lab Pipeline

    Bio-IT World | AWS this week announced Amazon Bio Discovery, a new AI-powered application designed to help scientists design novel drugs quickly and send them to wet lab partners for synthesizing and testing.

    Apr 15, 2026

  • PARTAGE Method Reveals Genome Regulation in Single Approach

    Bio-IT World | Researchers at the University of Minnesota Medical School propose PARTAGE, a multiomics approach that allows researchers to measure replication timing, changes in copy number, and gene activity from the same DNA sample.

    Apr 14, 2026

  • CAS Releases Agentic Tool for Literature Discovery

    Bio-IT World | CAS, a division of the American Chemical Society, has launched CAS Newton, science-smart agentic AI built specifically for scientific discovery. CAS Newton is grounded in published scientific knowledge curated by CAS scientists, drawing on more than 150 years of literature within the CAS Content Collection across chemistry, biology, materials science, and intellectual property to ensure accuracy and scientific rigor.

    Apr 10, 2026